PCN54 ESTIMATING THE CLINICAL BENEFITS OF HPV-16/18 VACCINATION- CHALLENGES OF MODELING PREDICTED CASES OF CERVICAL CANCER IN POLAND AND MEXICO, TWO COUNTRIES WITH DIFFERING DEGREES OF CERVICAL DISEASE AND POPULATION STABILITY
Abstract
Authors
RM Rogoza B Standaert